| Long name: |
ETEA Primary Polyclonal Antibody |
| Also known as: |
ETEA PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
ETEA |
| Specificity: |
This is a highly specific antibody against ETEA |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human ETEA |
| Gene ID number: |
23197 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
ETEA may be involved in the resistance to apoptosis in T cells and eosinophils of AD patients, ETEA shows higher expression in T cells and eosinophils of patients with AD than in T cells and eosinophils of unaffected individuals, Other atopic diseases such as hay fever, T cells are influential in the regulation of the inflammatory process of this disease, The persistence of jAD is attributed to dysregulated apoptosis in T cells, a chronic noncontagious relapsing inflammatory skin disease characterized by eczematous skin lesions and also referred to as eczematous dermatitis, and keratinocytes, asthma and conjunctivitis often occur along with AD, eosinophils, ETEA is a 445-amino acid protein associated with atopic dermatitis (AD) |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
FAF2_HUMAN, FAS-associated factor 2, Fas associated factor family member 2, KIAA0887, Protein ETEA, Protein expressed in T cells and eosinophils in atopic dermatitis, Protein expressed in T-cells and eosinophils in atopic dermatitis, UBX domain containing 8, UBX domain protein 3B, UBX domain-containing protein 3B, UBX domain-containing protein 8, UBXD8, UBXN3B, expressed in T cells and eosinophils in atopic dermatitis, faf2, AI462440 |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
ETEA |
| Short name: |
ETEA Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
ETEA (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
24666 |
| Gene: |
FAF2 |
More about : FAF2 |
| Long gene name: |
Fas associated factor family member 2 |
| Synonyms gene: |
UBXD8 |
| Synonyms gene name: |
UBX domain containing 8 |
| Synonyms: |
ETEA KIAA0887 UBXN3B |
| Synonyms name: |
expressed in T cells and eosinophils in atopic dermatitis UBX domain protein 3B |
| Locus: |
5q35, 2 |
| Discovery year: |
2006-01-06 |
| GenBank acession: |
BC015791 |
| Entrez gene record: |
23197 |
| Pubmed identfication: |
10048485 12372427 |
| RefSeq identity: |
NM_014613 |
| Classification: |
UBX domain containing |
| Havana BLAST/BLAT: |
OTTHUMG00000163228 |